Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.51 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.51 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.46 |
| ▸ | JUN | P05412 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL489472 | 1.00 | PTGER4 (0.51) | PTGER4PTGER3PTGER2THRBATM | |
| Cinnamic Acid SCHEMBL20555429 | 0.92 | PTGER4 (0.57) | PTGER4PTGER3PTGER2THRBATM | |
| Cinnamic Acid SCHEMBL20555426 | 0.92 | PTGER4 (0.57) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL5178122 | 0.92 | PTGER4 (0.49) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL6367849 | 0.92 | PTGER4 (0.49) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL5150459 | 0.91 | PTGER4 (0.48) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL2490381 | 0.91 | PTGER4 (0.48) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL285246 | 0.90 | PTGER4 (0.54) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL285247 | 0.90 | PTGER4 (0.54) | PTGER4PTGER3PTGER2THRBATM | |
| SCHEMBL39940 | 0.89 | PTGER4 (0.47) | PTGER4PTGER3PTGER2THRBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102356121-A | Uv and light protective film | HUHTAMAKI FORCHHEIM | 2012-02-15 | — | — | CN | claimed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2026106274-A1 | HAIR COSMETIC COMPOSITION HAVING EXCELLENT PHOTOPROTECTIVE EFFICACY | 한국콜마주식회사 | 2026-05-21 | — | — | WO | disclosed |
| US-12589062-B2 | Powdery solid cosmetic preparation | SHISEIDO COMPANY, LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | DOW TORAY CO LTD (JP) | 2026-03-19 | — | — | US | disclosed |
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4628568-A1 | GEL CLEANING AGENT AND METHOD FOR PRODUCING THE SAME | Shiseido Honeycake Industries Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-4626941-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESSTHEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | Dow Toray Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-4620453-A1 | AQUEOUS DISPERSION OF SURFACE-HYDROPHOBIZED INORGANIC POWDER AND COSMETIC PREPARATION CONTAINING SAME | Nikko Chemicals Co., Ltd. (JP) | 2025-09-24 | — | — | EP | disclosed |
| US-20250283012-A1 | GEL CLEANING AGENT AND METHOD FOR PRODUCING THE SAME | SHISEIDO HONEYCAKE INDUSTRIES CO., LTD. (JP) | 2025-09-11 | — | — | US | disclosed |
| US-20020193875-A1 | Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin | SHISEIDO COMPANY, LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-1180371-A1 | AGENTS PROMOTING THE FORMATION OF SKIN BASEMENT MEMBRANE, AGENTS PROMOTING THE FORMATION OF ARTIFICIAL SKIN AND PROCESS FOR PRODUCING ARTIFICIAL SKIN | SHISEIDO COMPANY LIMITED (JP) | 2002-02-20 | — | — | EP | disclosed |
| EP-1165039-A2 | DERMATOLOGICAL TOPICAL COMPOSITION | Pentapharm A.G. (CH) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001091715-A2 | TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE | PENTAPHARM LTD. (CH) | 2001-12-06 | — | — | WO | disclosed |
| EP-1153602-A1 | SKIN PREPARATIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-6150425-A | COMPRISING AN OUTER PHASE OIL AND OIL IN WATER EMULSION IN THE INNER PHASE WHICH CONTAINING WATER, AN OIL BASED INGREDIENT, A SURFACTANT AND AN AMPHIPHILIC SUBSTANCE; PREPARED BY A HIGH PRESSURE OR ULTRASONIC EMULSIFICATION | SHISEIDO COMPANY, LTD. (JP) | 2000-11-21 | — | — | US | disclosed |
| WO-2000057840-A2 | DERMATOLOGICAL TOPICAL COMPOSITION | PENTAPHARM AG (CH) | 2000-10-05 | — | — | WO | disclosed |
| EP-1002515-A1 | SKIN COMPOSITIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2000-05-24 | — | — | EP | disclosed |
| EP-0970741-A1 | O/W/O TYPE MULTIPHASE EMULSION | SHISEIDO COMPANY LIMITED (JP) | 2000-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SGMS1, SGMS2, CETP | PTGER4 233/4885PTGER3 449/4885PTGER2 407/4885 |
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | FOXM1, FOXK1, TAF1L | PTGER4 1551/4885PTGER3 1191/4885PTGER2 666/4885 |
| US-12589062-B2 | Powdery solid cosmetic preparation | TMEM63A, CUTA, VCL | PTGER4 3247/4885PTGER3 1724/4885PTGER2 2922/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | PTGER4 520/4885PTGER3 1437/4885PTGER2 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.